Cheng Z - Search Results

1

Prognostic value of HMGN family expression in acute myeloid leukemia.

Cui W, Liu Y, Tan Y, Peng X, Cui L, Cheng Z, Dai Y, Fu L, Zeng T, Liu Y. Cui W, et al. Among authors: cheng z. Future Oncol. 2021 Feb;17(5):541-548. doi: 10.2217/fon-2020-0555. Epub 2021 Jan 20. Future Oncol. 2021. PMID: 33467898

2

Molecular predictors of post-transplant survival in acute myeloid leukemia.

Qin T, Wu S, Zhao H, Xu K, Fu H, Cheng Z, Pang Y, Han Y, Chen L, Wang C, Zhang Y, Ke X, Xu K, Shi J, Fu L. Qin T, et al. Among authors: cheng z. Blood Cancer J. 2017 Dec 13;7(12):641. doi: 10.1038/s41408-017-0027-6. Blood Cancer J. 2017. PMID: 29233964 Free PMC article. No abstract available.

3

High PD-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma.

Cheng Z, Dai Y, Wang J, Shi J, Ke X, Fu L. Cheng Z, et al. Ann Hematol. 2018 Jun;97(6):1085-1088. doi: 10.1007/s00277-018-3266-0. Epub 2018 Feb 20. Ann Hematol. 2018. PMID: 29464311 No abstract available.

4

Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5.

Cheng Z, Hu K, Tian L, Dai Y, Pang Y, Cui W, Zhao H, Qin T, Han Y, Hu N, Chen L, Wang C, Zhang Y, Wu D, Ke X, Shi J, Fu L. Cheng Z, et al. Cancer Gene Ther. 2018 May;25(3-4):77-83. doi: 10.1038/s41417-018-0013-6. Epub 2018 Feb 28. Cancer Gene Ther. 2018. PMID: 29491461

5

Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

Cheng Z, Zhou L, Hu K, Dai Y, Pang Y, Zhao H, Wu S, Qin T, Han Y, Hu N, Chen L, Wang C, Zhang Y, Wu D, Ke X, Shi J, Fu L. Cheng Z, et al. Bone Marrow Transplant. 2018 Sep;53(9):1089-1095. doi: 10.1038/s41409-018-0146-0. Epub 2018 Mar 7. Bone Marrow Transplant. 2018. PMID: 29515250

6

Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.

Wu S, Dai Y, Zhang Y, Wang X, Wang L, Ma D, Zhang L, Pang Y, Jiao Y, Niu M, Xu K, Ke X, Shi J, Cheng Z, Fu L. Wu S, et al. Among authors: cheng z. Cancer Gene Ther. 2018 Aug;25(7-8):207-213. doi: 10.1038/s41417-018-0028-z. Epub 2018 Jun 15. Cancer Gene Ther. 2018. PMID: 29904089

7

Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia.

Cheng Z, Dai Y, Pang Y, Jiao Y, Zhao H, Zhang Z, Qin T, Hu N, Zhang Y, Ke X, Chen Y, Wu D, Shi J, Fu L. Cheng Z, et al. Cancer Gene Ther. 2019 Feb;26(1-2):17-25. doi: 10.1038/s41417-018-0027-0. Epub 2018 Jun 18. Cancer Gene Ther. 2019. PMID: 29910468

8

Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.

Cheng Z, Dai Y, Pang Y, Jiao Y, Zhao H, Wu S, Zhang L, Zhang Y, Wang X, Wang L, Ma D, Qin T, Hu N, Zhang Y, Hu K, Zhang Q, Shi J, Fu L. Cheng Z, et al. Cell Physiol Biochem. 2018;47(5):1853-1861. doi: 10.1159/000491065. Epub 2018 Jun 29. Cell Physiol Biochem. 2018. PMID: 29961066 Free article. Clinical Trial.

9

Prognostic role of DOK family adapters in acute myeloid leukemia.

Zhang L, Li R, Hu K, Dai Y, Pang Y, Jiao Y, Liu Y, Cui L, Shi J, Cheng Z, Fu L. Zhang L, et al. Among authors: cheng z. Cancer Gene Ther. 2019 Sep;26(9-10):305-312. doi: 10.1038/s41417-018-0052-z. Epub 2018 Oct 22. Cancer Gene Ther. 2019. PMID: 30348947

10

Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.

Cui L, Cheng Z, Liu Y, Dai Y, Pang Y, Jiao Y, Ke X, Cui W, Zhang Q, Shi J, Fu L. Cui L, et al. Among authors: cheng z. Cancer Gene Ther. 2020 Feb;27(1-2):15-21. doi: 10.1038/s41417-018-0071-9. Epub 2018 Dec 22. Cancer Gene Ther. 2020. PMID: 30578412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,475 results

Search Page